Renaissance Global Limited (NSE:RGL)

Sage Therapeutics Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,458	512.56	1,315	1,854	1,864
Short-Term Investments	960.45	1,360	1,080	721.74	108.81
Cash & Short-Term Investments	2,419	1,872	2,395	2,575	1,973
Cash Growth	29.18%	-21.81%	-7.02%	30.53%	30.46%
Accounts Receivable	7,080	4,824	4,453	4,470	3,796
Other Receivables	-	15.46	23.86	287.65	516.29
Receivables	7,111	4,912	4,517	4,786	4,332
Inventory	9,648	9,691	8,615	9,395	8,449
Prepaid Expenses	-	142.89	137.16	123.63	65.72
Other Current Assets	403.24	433.14	364.47	333.39	373.04
Total Current Assets	19,580	17,051	16,028	17,213	15,192
Property, Plant & Equipment	2,032	2,076	2,138	1,901	705.58
Long-Term Investments	38.27	101.68	64.56	86.22	118.73
Goodwill	974.22	520.6	451.85	368	17.16
Other Intangible Assets	59.75	1.58	4.66	9.26	79.09
Long-Term Deferred Tax Assets	361.84	290.75	306.36	216.03	268.28
Long-Term Deferred Charges	-	45.3	49.81	51.98	-
Other Long-Term Assets	334.98	101.08	91.93	90.71	66.39
Total Assets	23,396	20,236	19,185	20,004	16,454
Accounts Payable	1,932	1,856	2,266	2,499	1,453
Accrued Expenses	28.22	152.11	132.13	109.24	62.49
Short-Term Debt	4,979	4,812	4,182	5,167	4,706
Current Portion of Long-Term Debt	-	-	9.76	693.43	158.01
Current Portion of Leases	106.25	107.3	126.03	130.14	121.54
Current Income Taxes Payable	58.79	1.67	-	-	-
Other Current Liabilities	541.14	169.73	389.93	383.32	352.59
Total Current Liabilities	7,645	7,098	7,105	8,982	6,854
Long-Term Debt	177.39	291.67	441.75	461.99	970.69
Long-Term Leases	1,347	1,344	1,359	1,306	180.7
Other Long-Term Liabilities	3.18	7.44	7.24	7.54	5.86
Total Liabilities	9,172	8,751	8,920	10,762	8,026
Common Stock	214.46	192.26	188.79	188.79	186.83
Additional Paid-In Capital	-	983.36	813.07	712.95	712.95
Retained Earnings	-	9,216	8,741	8,086	7,061
Comprehensive Income & Other	13,696	1,094	516.34	252.25	468.45
Total Common Equity	13,910	11,485	10,260	9,240	8,429
Minority Interest	313.12	-0.11	5.01	1.95	-1.81
Shareholders' Equity	14,223	11,485	10,265	9,241	8,428
Total Liabilities & Equity	23,396	20,236	19,185	20,004	16,454
Total Debt	6,610	6,555	6,118	7,758	6,137
Net Cash (Debt)	-4,191	-4,683	-3,724	-5,183	-4,164
Net Cash Per Share	-41.99	-48.81	-39.19	-54.91	-44.45
Filing Date Shares Outstanding	104.82	96.13	94.4	94.4	93.41
Total Common Shares Outstanding	104.82	96.13	94.4	94.4	93.41
Working Capital	11,935	9,953	8,923	8,231	8,338
Book Value Per Share	132.71	119.47	108.69	97.88	90.24
Tangible Book Value	12,876	10,963	9,803	8,862	8,333
Tangible Book Value Per Share	122.84	114.04	103.85	93.88	89.20
Land	-	12.33	12.29	12.08	12
Buildings	-	253.64	260.03	254.64	254.11
Machinery	-	1,463	1,328	1,174	1,102
Construction In Progress	-	13.52	17.69	94.88	0.59
Leasehold Improvements	-	333.2	323.13	140.24	138.09

Source: S&P Global Market Intelligence. Standard template. Financial Sources.